Want to track GMAB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Genmab A/S (GMAB) Statistics
Valuation metrics
Market Cap -
Enterprise value 26.27B
Trailing P/E (ttm) 28.63
Forward P/E -
PEG ratio -0.33
Price/Sales (ttm) 2.33
Price/Book (mrq) 3.77
Enterprise Value/Revenue 2.72
Enterprise Value/EBITDA 18.85
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 177.33K
Average volume (90 days) 120.6K
Price summary
52-Week low 1,275
52-Week high 2,257
Beta -
50-Day moving average 2,233.28
200-Day moving average 1,900.1
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.08%
Operating margin 0.14%
Operational effectiveness
Return on assets 0.06%
Return on equity 0.14%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 157.23
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 12.85
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 24.5
Total debt (mrq) -
Total Debt/Equity (mrq) 0.89
Current ratio (mrq) 2.46%
Book value per share (mrq) 97.12
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
